185 related articles for article (PubMed ID: 17490913)
1. Second-generation endometrial ablation treatment: Novasure.
Bongers MY
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
Kleijn JH; Engels R; Bourdrez P; Mol BW; Bongers MY
BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
[TBL] [Abstract][Full Text] [Related]
3. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
Gallinat A
Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
[TBL] [Abstract][Full Text] [Related]
4. Endometrial ablation with NovaSure GEA, a pilot study.
Busund B; Erno LE; Grønmark A; Istre O
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation.
Bongers MY; Bourdrez P; Mol BW; Heintz AP; Brölmann HA
BJOG; 2004 Oct; 111(10):1095-102. PubMed ID: 15383112
[TBL] [Abstract][Full Text] [Related]
6. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
Gallinat A
J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
[TBL] [Abstract][Full Text] [Related]
7. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
8. Thermoregulated radiofrequency endometrial ablation.
Dequesne JH; Gallinat A; Garza-Leal JG; Sutton CJ; van der Pas HF; Wamsteker K; Chandler JG
Int J Fertil Womens Med; 1997; 42(5):311-8. PubMed ID: 9406837
[TBL] [Abstract][Full Text] [Related]
9. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
Fulop T; Rákóczi I; Barna I
J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
[TBL] [Abstract][Full Text] [Related]
10. Health technology assessment of surgical therapies for benign gynaecological disease.
Owusu-Ansah R; Gatongi D; Chien PF
Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):841-79. PubMed ID: 17145485
[TBL] [Abstract][Full Text] [Related]
11. New endometrial ablation techniques for treatment of menorrhagia.
Bradley LD
Surg Technol Int; 2004; 12():161-70. PubMed ID: 15455321
[TBL] [Abstract][Full Text] [Related]
12. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia.
Cooper J; Gimpelson R; Laberge P; Galen D; Garza-Leal JG; Scott J; Leyland N; Martyn P; Liu J
J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):418-28. PubMed ID: 12386350
[TBL] [Abstract][Full Text] [Related]
13. Prospective observational study of Thermablate Endometrial Ablation System as an outpatient procedure.
Prasad P; Powell MC
J Minim Invasive Gynecol; 2008; 15(4):476-9. PubMed ID: 18602047
[TBL] [Abstract][Full Text] [Related]
14. Assessment and comparison of intraoperative and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems.
Laberge PY; Sabbah R; Fortin C; Gallinat A
J Am Assoc Gynecol Laparosc; 2003 May; 10(2):223-32. PubMed ID: 12732777
[TBL] [Abstract][Full Text] [Related]
15. Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices.
Cooper J; Gimpelson RJ
J Reprod Med; 2004 Apr; 49(4):267-73. PubMed ID: 15134151
[TBL] [Abstract][Full Text] [Related]
16. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases.
Baskett TF; Clough H; Scott TA
J Obstet Gynaecol Can; 2005 May; 27(5):473-6. PubMed ID: 16100642
[TBL] [Abstract][Full Text] [Related]
17. Global endometrial ablation for menorrhagia in women with bleeding disorders.
El-Nashar SA; Hopkins MR; Feitoza SS; Pruthi RK; Barnes SA; Gebhart JB; Cliby WA; Famuyide AO
Obstet Gynecol; 2007 Jun; 109(6):1381-7. PubMed ID: 17540811
[TBL] [Abstract][Full Text] [Related]
18. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
[TBL] [Abstract][Full Text] [Related]
19. Pathology of the NovaSure (radio-frequency) impedance-controlled endometrial ablation system.
Fadare O; Qin L; Martel M; Tavassoli FA
Arch Pathol Lab Med; 2005 Sep; 129(9):1175-8. PubMed ID: 16119995
[TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of endometrial ablation.
Fürst SN; Philipsen T; Joergensen JC
Acta Obstet Gynecol Scand; 2007; 86(3):334-8. PubMed ID: 17364309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
